Transgene operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Transgene with three other
pharmaceutical manufacturers in Europe:
Biomed Lublin Wytwornia Surowic I Szczepionek SA
sales of 42.59 million Polish New Zlotys [US$10.45 million]
Co Don AG
(5.09 million Euro [US$5.45 million]
of which 100%
was Product sales), and
based in Germany
(5.62 million Euro [US$6.02 million]
During the year ended December of 2015, sales at
Transgene were 9.57 million Euro (US$10.25 million).
decrease of 18.6%
versus 2014, when the company's sales were 11.75 million Euro.
Contributing to the drop in overall sales was the 55.5% decline
in Research and Development Subsidies, from 551,000.00 Euro to 245,000.00 Euro.
There were also decreases in sales in
Research and Development Tax Credit (down 9.8% to 7.86 million Euro)
Bio-Production and Cooperations (down 52.2% to 798,000.00 Euro)
Royalties and Licenses (down 18.9% to 667,000.00 Euro)